A collaborative symposium integrating industry, academia, and the clinic, discussing the latest advances in cancer drug discovery and immunotherapies.
This unique free full-day symposium, a collaboration between Cancer Therapeutics CRC (CTx), Merck Sharp & Dohme (MSD), and the Victorian Comprehensive Cancer Centre (VCCC), brings together leading industry, academic and clinical experts to discuss opportunities to progress biological discoveries to effective therapies, covering cancer drug discovery, development, and immunotherapies.
Who should attend?
This day of discussion and discovery will suit biomedical PhD students, researchers, clinical and allied health professionals, medical and pharmaceutical investors and life science analysts.
Three program sessions cover “Harnessing the immune system to fight cancer”, “From biological discoveries to therapies”, and “Finding the right patients”. In addition to an exciting mix of local speakers, we will be joined by four keynote international speakers; John Connolly from the Agency for Science, Technology and Research Singapore, Dr Michael Rosenzweig, Executive Director, Biology-Discovery, MSD, Dr Jonathan Bennett, Associate Vic President Discovery Chemistry, MSD and Dr Rachel Altura, MD, Clinical Director, Early Oncology Development MSD.
Tuesday 30 October 2018
Register from 9.00am
9.15am – 4.15pm followed by networking event and refreshments
The Copland Theatre (B01), Basement
The University of Melbourne
198 Berkeley Street, Parkville
This is a free event but numbers are limited and registration is essential.